379 related articles for article (PubMed ID: 18801533)
1. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
Kuo NW; Lin HC; Lee HC
J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
[TBL] [Abstract][Full Text] [Related]
2. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen testing in men older than 75 years in the United States.
Scales CD; Curtis LH; Norris RD; Schulman KA; Albala DM; Moul JW
J Urol; 2006 Aug; 176(2):511-4. PubMed ID: 16813879
[TBL] [Abstract][Full Text] [Related]
5. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
McNaughton Collins M; Stafford RS; Barry MJ
J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and practices of primary care physicians for prostate cancer screening.
Hoffman RM; Papenfuss MR; Buller DB; Moon TE
Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database.
D'Ambrosio GG; Campo S; Cancian M; Pecchioli S; Mazzaglia G
Eur J Cancer Prev; 2010 Nov; 19(6):413-6. PubMed ID: 20679895
[TBL] [Abstract][Full Text] [Related]
11. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
12. Screening for prostate cancer: a survey of New Zealand general practitioners.
Durham J; Low M; McLeod D
N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
[TBL] [Abstract][Full Text] [Related]
13. Mass screening for prostate cancer in Korea: a population based study.
Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY;
J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541
[TBL] [Abstract][Full Text] [Related]
14. Trends in prostate-specific antigen testing from 1995 through 2004.
Farwell WR; Linder JA; Jha AK
Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
[TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer: a comparison of urologists and primary care physicians.
McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
Kell JS
Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
[TBL] [Abstract][Full Text] [Related]
17. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
Bunting PS
Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
[TBL] [Abstract][Full Text] [Related]
18. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.
Moul JW; Sun L; Hotaling JM; Fitzsimons NJ; Polascik TJ; Robertson CN; Dahm P; Anscher MS; Mouraviev V; Pappas PA; Albala DM
J Urol; 2007 Feb; 177(2):499-503; discussion 503-4. PubMed ID: 17222618
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen testing: uncovering primary care influences.
Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
[TBL] [Abstract][Full Text] [Related]
20. PSA testing in general practice.
Little B; Ho KJ; Gormley G; Young M
Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
